Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.45 |
| ▸ | ACP3 | P15309 | 1/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16807280 | 0.90 | L3MBTL1 (0.56) | L3MBTL1TDP1MDM2MEN1KMT2A | |
| SCHEMBL16807284 | 0.89 | L3MBTL1 (0.69) | L3MBTL1TDP1KCNK3ACP3MEN1 | |
| SCHEMBL16807274 | 0.86 | L3MBTL1 (0.59) | L3MBTL1TDP1NPC1RAB9AMEN1 | |
| SCHEMBL16807273 | 0.85 | L3MBTL1 (0.62) | L3MBTL1TDP1ACP3MEN1KMT2A | |
| SCHEMBL16781984 | 0.84 | L3MBTL1 (0.70) | L3MBTL1TDP1MEN1KMT2APOLB | |
| SCHEMBL16781983 | 0.84 | L3MBTL1 (0.56) | L3MBTL1TDP1MDM2MEN1KMT2A | |
| SCHEMBL16781985 | 0.82 | TDP1 (0.54) | L3MBTL1TDP1MDM2NPC1RAB9A | |
| SCHEMBL16807282 | 0.82 | TDP1 (0.50) | L3MBTL1TDP1MDM2NPC1RAB9A | |
| SCHEMBL16781981 | 0.79 | CES2 (0.51) | L3MBTL1TDP1ACP3MDM2MEN1 | |
| SCHEMBL7589819 | 0.79 | L3MBTL1 (0.73) | L3MBTL1TDP1MAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656947-B2 | Process for creating carbon-carbon bonds using carbonyl compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2017-05-23 | — | — | US | disclosed |
| US-9656947-B2 | Process for creating carbon-carbon bonds using carbonyl compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2017-05-23 | — | — | US | disclosed |
| EP-2858966-B1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NAT RECH SCIENT (FR) | 2016-08-10 | — | — | EP | disclosed |
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. R.S.) (FR) | 2015-06-18 | — | — | US | disclosed |
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. R.S.) (FR) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CBR3, CBR1, CYP4F3 | L3MBTL1 4386/4885TDP1 4876/4885MAOA 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.